Patent 7935804 was granted and assigned to Aduro Biotech on May, 2011 by the United States Patent and Trademark Office.
The invention provides a bacterium containing a polynucleotide comprising a nucleic acid encoding a heterologous antigen, as well as fusion protein partners. Also provided are vectors for mediating site-specific recombination and vectors comprising removable antibiotic resistance genes.